Health
Pfizer’s anti-viral 3CL protease inhibitor shows antiviral potential against SARS-CoV-2 – News-Medical.Net
Now, a new study by researchers from Pfizer, University of Arizona, Purdue University, The Scripps Research Institute, and UC San Diego School of Medicine and published on the preprint server bioRxiv in September 2020 reports that an enzyme inhibitor may act …
The COVID-19 pandemic has still not been countered by effective drugs or antivirals, which is the reason for the continued restrictions on mobility and social interactions in most countries the world over. Now, a new study by researchers from Pfizer, University of Arizona, Purdue University, The Scripps Research Institute, and UC San Diego School of Medicine and published on the preprint server bioRxiv* in September 2020 reports that an enzyme inhibitor may act in synergism with the approved ant…
-
General24 hours agoEmergency operation underway after reports of bodies north-east of Falls Creek
-
Noosa News24 hours agoBroncos and Roosters set for ‘Queensland versus NSW rivalry’ in NRLW grand final
-
Noosa News22 hours agoWhy Brisbane needs to (re)embrace Los Angeles
-
General22 hours agoUK names Sarah Mullally as first female Archbishop of Canterbury to lead Church of England